Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IZN 6N-AV

Next Previous
X
Search
Drug Profile

IZN 6N-AV

Alternative Names: Centella-asiatica/Echinacea-purpurea/Sambucus-nigra; IZN 6N VS; IZN-6N-AV

Latest Information Update: 16 Jul 2016

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Izun Pharma
  • Class Anti-inflammatories; Herbal medicines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Vaginitis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Vaginitis in Israel (Topical, Cream)
  • 01 Dec 2014 Izun Pharmaceuticals initiates a phase I/II trial in Vaginitis in Israel (NCT02313545)
  • 13 May 2013 Izun Pharmaceuticals plans a proof-of-concept trial for Vaginitis in Israel

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top